New drug trial targets breast cancer in the brain

NCT ID NCT06048718

Summary

This study is testing a drug called Trastuzumab-Deruxtecan (T-DXd) for people with a specific type of advanced breast cancer (HER2-low) that has spread to the brain. The main goal is to see how well the drug shrinks these brain tumors. It will also track side effects and how the treatment affects patients' daily life and neurological function.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Hospital Arnau de Vilanova de Valencia

    Valencia, Valencia, 46015, Spain

  • Hospital Beata María Ana

    Madrid, Madrid, 28007, Spain

  • Hospital Clínico Universitario de Valencia

    Valencia, Valencia, 46010, Spain

  • Hospital Universitari Dexeus

    Barcelona, Barcelona, 08028, Spain

  • Hospital Universitari Vall D'Hebron

    Barcelona, Barcelona, 08035, Spain

  • Hospital Universitario Clínico San Cecilio de Granada

    Granada, Granada, 18016, Spain

  • Hospital Universitario Ramón y Cajal

    Madrid, Madrid, 28034, Spain

  • Hospital Universitario Reina Sofía

    Córdoba, Córdoba, 14004, Spain

  • Hospital Universitario San Juan de Alicante

    Alicante, Alicante, 03550, Spain

  • Hospital Universitario Virgen del Rocío

    Seville, Sevilla, 41013, Spain

  • Hospital Universitario de Basurto

    Bilbao, Bilbao, 48013, Spain

  • Medical University of Vienna

    Vienna, 1090, Austria

  • Salzburg Cancer research Institute-Center

    Salzburg, Austria

Conditions

Explore the condition pages connected to this study.